feedback

Course Director

Marc S. Sabatine, MD, MPH
Marc S. Sabatine, MD, MPH

TIMI Study Group
Brigham and Women's Hospital
Harvard Medical School
Boston, Massachusetts

Accredited by

University of Florida College of Medicine

Activity Details

Credit Types:CME
Credit Amount:0.5 Credits
Release Date:2017-Mar-02
Expiration Date:2018-Mar-01
Estimated Time for Completion:30 minutes
Registration Required:No
Cost:Free of charge

Activity Description and Educational Objectives

In this activity, an expert in cardiovascular disease discusses the use of PCSK9 inhibition in patients with hypercholesterolemia. In addition to providing insight on recent efficacy, safety, and cardiovascular outcomes data, practical perspectives are offered on tailoring therapy to the individual patient.

Upon completion of this activity, participants should be better able to:
  • Evaluate PCSK9 inhibitor therapy based on recent efficacy, safety, and cardiovascular outcomes data
  • Implement PSCK9 inhibitor therapy for hypercholesterolemia management according to patient preferences and cardiovascular risk

Target Audience

This activity has been designed to meet the educational needs of cardiologists, endocrinologists, lipidologists, managed care medical directors, and other clinicians involved in the treatment of hypercholesterolemia.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Enduring Material
Release and Expiration Dates: March 02, 2017 - March 01, 2018
Time to Complete: 30 minutes

Faculty & Disclosure / Conflict of Interest Policy

In accordance with ACCME requirements, the University of Florida College of Medicine has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.

Course Director

Marc S. Sabatine, MD, MPH
Chairman, TIMI Study Group
Lewis Dexter, MD, Distinguished Chair in Cardiovascular Medicine
Brigham and Women's Hospital
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Marc S. Sabatine, MD, MPH, has a financial interest/relationship or affiliation in the form of:
Consultant for Amgen Inc.; AstraZeneca; CVS Caremark; Ionis Pharmaceuticals; MedImmune; and Merck & Co., Inc.
Grant/Research Support from Amgen Inc.; AstraZeneca; Daiichi Sankyo, Inc.; Eisai Inc.; GlaxoSmithKline; Intarcia Therapeutics, Inc.; Janssen Pharmaceuticals, Inc. (Research Development); MedImmune; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Poxel; and Takeda Pharmaceuticals U.S.A., Inc.

CME Reviewer

Jamie B. Conti, MD, FACC, FHRS
Professor of Medicine
Chief, Division of Cardiovascular Medicine
AHA Eminent Scholar in Cardiology
Department of Medicine
University of Florida College of Medicine
Gainesville, Florida

Jamie B. Conti, MD, FACC, FHRS, has no financial interests/relationships or affiliations in relation to this activity.

Medical Director

Chris Washburn, PhD
PVI, PeerView Institute for Medical Education

Chris Washburn, PhD, has no financial interests/relationships or affiliations in relation to this activity.

Providership, Credit & Support

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Florida College of Medicine and PVI, PeerView Institute for Medical Education. The University of Florida College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Florida College of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Providership

This CME activity is jointly provided by the University of Florida College of Medicine and PVI, PeerView Institute for Medical Education.

Support

This activity is supported by an educational donation provided by Amgen.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView Press or any of its partners, providers, and/or supporters.


Copyright © 2000-2017, PeerView Press - Medical Education Resource

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.